Cargando…

Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990

Quercetin can significantly inhibit the progression of colorectal cancer (CRC). However, its specific mechanism remains largely unclear. In this study, we aimed to explore the correlation among quercetin, tumour-associated macrophages (TAMs) and circular RNAs (circRNAs) in the progression of CRC and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bin, Wu, Linguangjin, Tang, Xiaoxia, Wang, Ting, Wang, Shuyun, Yu, Hongjie, Wan, Guangsheng, Xie, Manli, Zhang, Ruijuan, Xiao, Haijuan, Deng, Wanli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158466/ https://www.ncbi.nlm.nih.gov/pubmed/35662705 http://dx.doi.org/10.3389/fphar.2022.874696

Ejemplares similares

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990
por: Frontiers Editorial Office
Publicado: (2023)

Hsa_circ_0043278 Inhibits Tumorigenesis and is Downregulated in Colorectal Cancer
por: Wang, Jiali, et al.
Publicado: (2021)

Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in Pancreatic Cancer
por: Ye, Zhenyu, et al.
Publicado: (2020)

hsa_circ_0072389, hsa_circ_0072386, hsa_circ_0008621, hsa_circ_0072387, and hsa_circ_0072391 aggravate glioma via miR-338-5p/IKBIP
por: Liang, Jian, et al.
Publicado: (2021)

Serum and Serum Exosomal CircRNAs hsa_circ_0001492, hsa_circ_0001439, and hsa_circ_0000896 as Diagnostic Biomarkers for Lung Adenocarcinoma
por: Kang, Yanli, et al.
Publicado: (2022)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma
por: Jiang, Zhenluo, et al.
Publicado: (2019)

hsa_circ_0006459 and hsa_circ_0015962 affect prognosis of Dengue fever
por: He, JinHua, et al.
Publicado: (2019)

Potential roles of hsa_circ_000839 and hsa_circ_0005986 in breast cancer
por: Firoozi, Zahra, et al.
Publicado: (2022)

Clinical significances of hsa_circ_0067582 and hsa_circ_0005758 in gastric cancer tissues
por: Lu, Rongdan, et al.
Publicado: (2019)

CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML
por: Zhong, An-Ni, et al.
Publicado: (2021)

Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
por: Luo, Ning, et al.
Publicado: (2022)

Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer
por: Hong, Lu, et al.
Publicado: (2022)

Bioinformatics Analysis: The Regulatory Network of hsa_circ_0007843 and hsa_circ_0007331 in Colon Cancer
por: Han, Zeping, et al.
Publicado: (2021)

Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma
por: Chen, Gaoyang, et al.
Publicado: (2018)

Circular RNAs Hsa_circ_101555 and Hsa_circ_008068 as Diagnostic Biomarkers for Early-Stage Lung Adenocarcinoma
por: Lian, Xue, et al.
Publicado: (2022)

Plasma Circular RNAs hsa_circ_0001953 and hsa_circ_0009024 as Diagnostic Biomarkers for Active Tuberculosis
por: Huang, Zikun, et al.
Publicado: (2018)

Downregulated Expression of hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance
por: Yang, Liangwei, et al.
Publicado: (2019)

Identification of circular RNAs hsa_circ_0044235 and hsa_circ_0068367 as novel biomarkers for systemic lupus erythematosus
por: Luo, Qing, et al.
Publicado: (2019)

Expression Profiles of circRNAs and Identification of hsa_circ_0007608 and hsa_circ_0064656 as Potential Biomarkers for COPD-PH Patients
por: Yu, Jinyan, et al.
Publicado: (2023)

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
por: Liu, Ruoyu, et al.
Publicado: (2021)

Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
por: Guo, Shanshan, et al.
Publicado: (2020)

Circular RNA hsa_circ_009755 downregulation correlates with clinicopathology in oral squamous cell carcinoma
por: Wang, Zihong, et al.
Publicado: (2019)

Circular RNA hsa_circ_0005046 and hsa_circ_0001791 May Become Diagnostic Biomarkers for Breast Cancer Early Detection
por: Ameli-Mojarad, Melika, et al.
Publicado: (2021)

Hsa_Circ_0098181 Suppresses Hepatocellular Carcinoma by Sponging miR-18a-3p and Targeting PPARA
por: Luo, Yuan-Yuan, et al.
Publicado: (2022)

Circular RNA hsa_circ_0003574 as a biomarker for prediction and diagnosis of ischemic stroke caused by intracranial atherosclerotic stenosis
por: Li, Lingfei, et al.
Publicado: (2022)

Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis
por: Ji, Changle, et al.
Publicado: (2021)

Knockdown of hsa_circ_0008922 inhibits the progression of glioma
por: Xue, Chunhong, et al.
Publicado: (2022)

Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging
por: Chen, Shuifang, et al.
Publicado: (2020)

Circular RNAs Hsa_circ_0002715 and Hsa_circ_0035197 in Peripheral Blood Are Novel Potential Biomarkers for New-Onset Rheumatoid Arthritis
por: Luo, Qing, et al.
Publicado: (2019)

Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for Diabetic Kidney Disease in patients with type 2 diabetes mellitus
por: Badr, Amul M., et al.
Publicado: (2023)

Peripheral Blood circRNA Microarray Profiling Identities hsa_circ_0001831 and hsa_circ_0000867 as Two Novel circRNA Biomarkers for Early Type 2 Diabetic Nephropathy
por: Zhang, Keke, et al.
Publicado: (2022)

Hsa_circ_0001649 restrains gastric carcinoma growth and metastasis by downregulation of miR‐20a
por: Sun, Haiyuan, et al.
Publicado: (2020)

Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa‐miR‐1184 and releasing AJUBA and inactivating Hippo/YAP signalling
por: Wang, Xu, et al.
Publicado: (2020)

CircRNA hsa_circ_0004585 as a potential biomarker for colorectal cancer
por: Tian, Jinhai, et al.
Publicado: (2019)

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
por: Zhou, Lisha, et al.
Publicado: (2023)

Hsa_circ_0040809 and hsa_circ_0000467 promote colorectal cancer cells progression and construction of a circRNA-miRNA-mRNA network
por: Liu, Jingfu, et al.
Publicado: (2022)

Hsa_circ_0005729 enhances accuracy in diagnosing parathyroid carcinoma
por: Wang, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kn3e1gpvnmhi526nu3mvckhi13